Medical Device Reprocessing Market by Product (Reprocessed Device (Catheter, Endoscope, Laparoscopic Instruments, Biopsy, Pulse Oximeter), Service), Application (Cardiology, Gastroenterology, Arthroscopy, Orthopedic, Anesthesia) - Global Forecast to 2022
出 版 商：MarketsandMarkets
出版日期：2017/06/19
頁 數：147頁
文件格式：PDF
價 格：
USD 5,650 (Single-User License)
USD 6,650 (Multi-User License)
USD 8,150 (Global-User License)
USD 6,650 (Multi-User License)
USD 8,150 (Global-User License)
The global medical device reprocessing market is estimated to grow at a CAGR of 16.3% from 2017 to 2022, to reach USD 1,754.0 million by 2022. The key factors driving the growth of this market include the low prices of reprocessed devices as compared to new ones and the pressure to reduce the volume of medical waste generated. However, the risk of transmission of surgical site infections associated with the use of reprocessed devices may hinder the growth of the market to a certain extent during the forecast period.
The reprocessing support and services segment is expected to grow at the highest CAGR
On the basis of product and service, the medical device reprocessing market is segmented into reprocessing support & service and reprocessed medical devices. The reprocessing support and services segment is expected to witness the highest growth during the forecast period. The growth of this segment is mainly due to the growing preference of third-party reprocessing of medical devices by hospitals, clinics, surgical centers, clinical pathologies, and other healthcare organizations, over in-house reprocessing practices.
The catheters segment to dominate the global medical device reprocessing market during the forecast period
Based on the type of medical device, the medical device reprocessing market is further classified into catheters; laparoscopic instruments; biopsy instruments; endoscopy instruments; cables, columns, curves, and cutters; and other reprocessed medical devices. The catheters segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to the increased utilization of reprocessed cardiology catheters, electrophysiology catheters, and diagnostic catheters in recent years.
The cardiology segment is projected to grow at the highest CAGR during the forecast period.
Based on application, the medical device reprocessing market is further segmented into cardiology; gastroenterology, urology, and gynecology; arthroscopy and orthopedic surgery; and general surgery and anesthesia. During the forecast period, the cardiology segment is expected to grow at the highest CAGR. This growth is mainly due to the increased utilization of reprocessed medical devices during cardiology procedures, growing prevalence of cardiovascular diseases, increasing number of cardiology procedures across the globe, and rising utilization of reprocessed cardiac catheters.
Europe to witness the highest growth during the forecast period (2017-2022)
North America held the largest share of the global medical device reprocessing market in 2016, while Europe is expected to witness the highest growth during 2017 to 2022. Growing healthcare expenditure, rising geriatric population, increasing number of surgical procedures associated with growing prevalence of chronic diseases, and rising awareness about the utilization of reprocessed medical devices are the key factors responsible for the growth of this market in the European region.
Break of primary participants was as mentioned below:
‧ By Company Type – Tier 1–45%, Tier 2–40% and Tier 3–15%
‧ By Designation – C-level–41%, Director Level–30%, Others–29%
‧ By Region – North America–38%, Europe–31%, Asia-Pacific–19%, RoW–12%
Some of the major market players in the medical device reprocessing market are Stryker Corporation (U.S.), Johnson & Johnson (U.S.), Vanguard AG (Germany), Medline ReNewal (U.S.), Medtronic plc (Ireland), SteriPro Canada, Inc., Pioneer Medical Devices AG (Germany), Vascular Solutions, Inc. (U.S.), HYGIA Health Services, Inc. (U.S.), ReNu Medical, Inc. (U.S.), SureTek Medical (U.S.), and Centurion Medical Products Corporation (U.S.).
Research Coverage:
The report analyzes the medical device reprocessing market and aims at estimating market size and future growth potential of this market based on various segments such as product and service, type of medical device, application, and region. The report also includes an in-depth regulatory analysis for various regions across the globe and competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies.
This report provides insights on the following pointers:
‧ Market Penetration: Comprehensive information on product and service portfolios offered by the top players in the global medical device reprocessing market. The report analyzes the global medical device reprocessing market by product and service, type of medical device, application, and region.
‧ Service Enhancement/Innovation: Detailed insights on upcoming trends and new service launches in the global medical device reprocessing market.
‧ Market Development: Comprehensive information on the lucrative emerging markets by product and service, type of medical device, application, and region.
‧ Market Diversification: Exhaustive information about new services or service enhancements, growing geographies, recent developments, and investments in the global medical device reprocessing market.
‧ Competitive Assessment: In-depth assessment of market shares, growth strategies, products, services, and capabilities of reprocessing of medical devices of leading players in the global market.
The reprocessing support and services segment is expected to grow at the highest CAGR
On the basis of product and service, the medical device reprocessing market is segmented into reprocessing support & service and reprocessed medical devices. The reprocessing support and services segment is expected to witness the highest growth during the forecast period. The growth of this segment is mainly due to the growing preference of third-party reprocessing of medical devices by hospitals, clinics, surgical centers, clinical pathologies, and other healthcare organizations, over in-house reprocessing practices.
The catheters segment to dominate the global medical device reprocessing market during the forecast period
Based on the type of medical device, the medical device reprocessing market is further classified into catheters; laparoscopic instruments; biopsy instruments; endoscopy instruments; cables, columns, curves, and cutters; and other reprocessed medical devices. The catheters segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to the increased utilization of reprocessed cardiology catheters, electrophysiology catheters, and diagnostic catheters in recent years.
The cardiology segment is projected to grow at the highest CAGR during the forecast period.
Based on application, the medical device reprocessing market is further segmented into cardiology; gastroenterology, urology, and gynecology; arthroscopy and orthopedic surgery; and general surgery and anesthesia. During the forecast period, the cardiology segment is expected to grow at the highest CAGR. This growth is mainly due to the increased utilization of reprocessed medical devices during cardiology procedures, growing prevalence of cardiovascular diseases, increasing number of cardiology procedures across the globe, and rising utilization of reprocessed cardiac catheters.
Europe to witness the highest growth during the forecast period (2017-2022)
North America held the largest share of the global medical device reprocessing market in 2016, while Europe is expected to witness the highest growth during 2017 to 2022. Growing healthcare expenditure, rising geriatric population, increasing number of surgical procedures associated with growing prevalence of chronic diseases, and rising awareness about the utilization of reprocessed medical devices are the key factors responsible for the growth of this market in the European region.
Break of primary participants was as mentioned below:
‧ By Company Type – Tier 1–45%, Tier 2–40% and Tier 3–15%
‧ By Designation – C-level–41%, Director Level–30%, Others–29%
‧ By Region – North America–38%, Europe–31%, Asia-Pacific–19%, RoW–12%
Some of the major market players in the medical device reprocessing market are Stryker Corporation (U.S.), Johnson & Johnson (U.S.), Vanguard AG (Germany), Medline ReNewal (U.S.), Medtronic plc (Ireland), SteriPro Canada, Inc., Pioneer Medical Devices AG (Germany), Vascular Solutions, Inc. (U.S.), HYGIA Health Services, Inc. (U.S.), ReNu Medical, Inc. (U.S.), SureTek Medical (U.S.), and Centurion Medical Products Corporation (U.S.).
Research Coverage:
The report analyzes the medical device reprocessing market and aims at estimating market size and future growth potential of this market based on various segments such as product and service, type of medical device, application, and region. The report also includes an in-depth regulatory analysis for various regions across the globe and competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies.
This report provides insights on the following pointers:
‧ Market Penetration: Comprehensive information on product and service portfolios offered by the top players in the global medical device reprocessing market. The report analyzes the global medical device reprocessing market by product and service, type of medical device, application, and region.
‧ Service Enhancement/Innovation: Detailed insights on upcoming trends and new service launches in the global medical device reprocessing market.
‧ Market Development: Comprehensive information on the lucrative emerging markets by product and service, type of medical device, application, and region.
‧ Market Diversification: Exhaustive information about new services or service enhancements, growing geographies, recent developments, and investments in the global medical device reprocessing market.
‧ Competitive Assessment: In-depth assessment of market shares, growth strategies, products, services, and capabilities of reprocessing of medical devices of leading players in the global market.
TABLE OF CONTENTS
1 INTRODUCTION 13
1.1 OBJECTIVES OF THE STUDY 13
1.2 MARKET DEFINITION 13
1.3 MARKET SCOPE 14
1.3.1 MARKETS COVERED 14
1.3.2 YEARS CONSIDERED FOR THE STUDY 15
1.4 CURRENCY 15
1.5 LIMITATIONS 15
1.6 STAKEHOLDERS 15
2 RESEARCH METHODOLOGY 16
2.1 RESEARCH APPROACH 16
2.1.1 SECONDARY SOURCES 17
2.1.1.1 Key data from secondary sources 17
2.1.2 PRIMARY SOURCES 18
2.1.2.1 Key data from primary sources 18
2.1.2.2 Key industry insights 19
2.2 MARKET SIZE ESTIMATION 20
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 22
2.4 MARKET SHARE ESTIMATION 23
2.5 ASSUMPTIONS FOR THE STUDY 23
3 EXECUTIVE SUMMARY 24
4 PREMIUM INSIGHTS 28
4.1 GLOBAL MEDICAL DEVICE REPROCESSING MARKET OVERVIEW 28
4.2 GLOBAL MEDICAL DEVICE REPROCESSING MARKET, BY TYPE OF DEVICE,
2017 VS, 2022 29
4.3 MEDICAL DEVICE REPROCESSING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 30
4.4 MEDICAL DEVICE REPROCESSING MARKET: GEOGRAPHIC MIX 31
5 MARKET OVERVIEW 32
5.1 INTRODUCTION 33
5.2 MARKET DYNAMICS 33
5.2.1 DRIVERS 34
5.2.1.1 Low prices of reprocessed medical devices 34
5.2.1.2 Pressure to reduce volume of regulated medical waste 35
?
5.2.2 RESTRAINTS 35
5.2.2.1 Risk of surgical site infections 35
5.2.3 OPPORTUNITIES 36
5.2.3.1 Regulatory changes favoring the adoption of medical device reprocessing 36
5.2.4 KEY CHALLENGES 37
5.2.4.1 Stringent regulations for medical device reprocessing practices 37
6 REGULATORY ANALYSIS 38
6.1 INTRODUCTION 38
6.1.1 NORTH AMERICA 39
6.1.1.1 U.S. 39
6.1.1.2 Canada 40
6.1.2 EUROPE 41
6.1.2.1 Germany 42
6.1.2.2 Rest of Europe 42
6.1.3 ASIA-PACIFIC (APAC) 42
6.1.3.1 Japan 42
6.1.3.2 Australia 42
6.1.3.3 Rest of APAC 42
6.1.4 LATIN AMERICA 43
6.1.5 MIDDLE EAST & AFRICA 43
7 GLOBAL MEDICAL DEVICE REPROCESSING MARKET,
BY PRODUCT & SERVICE 44
7.1 INTRODUCTION 45
7.2 REPROCESSING SUPPORT AND SERVICES 45
7.3 REPROCESSED MEDICAL DEVICES 47
8 GLOBAL MEDICAL DEVICE REPROCESSING MARKET,
BY TYPE OF MEDICAL DEVICE 50
8.1 INTRODUCTION 51
8.2 CATHETERS 52
8.3 LAPAROSCOPY INSTRUMENTS 53
8.4 CABLES, COLUMNS, CURVES, AND CUTTERS 54
8.5 BIOPSY INSTRUMENTS 55
8.6 ENDOSCOPY INSTRUMENTS 56
8.7 OTHER REPROCESSED MEDICAL DEVICES 57
?
9 GLOBAL MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION 58
9.1 INTRODUCTION 59
9.2 CARDIOLOGY 60
9.3 GASTROENTEROLOGY, UROLOGY, AND GYNECOLOGY 61
9.4 ARTHROSCOPY AND ORTHOPEDIC SURGERY 63
9.5 GENERAL SURGERY AND ANESTHESIA 64
10 GLOBAL MEDICAL DEVICE REPROCESSING MARKET, BY REGION 65
10.1 INTRODUCTION 66
10.2 NORTH AMERICA 68
10.2.1 U.S. 72
10.2.2 CANADA 74
10.3 EUROPE 76
10.3.1 GERMANY 80
10.3.2 U.K. 82
10.3.3 FRANCE 84
10.3.4 REST OF EUROPE 86
10.4 ASIA-PACIFIC 87
10.4.1 AUSTRALIA 90
10.4.2 JAPAN 92
10.5 REST OF THE WORLD (ROW) 94
10.5.1 LATIN AMERICA 96
10.5.2 MIDDLE EAST AND AFRICA 98
11 COMPETITIVE LANDSCAPE 101
11.1 VENDOR DIVE OVERVIEW 101
11.1.1 VANGUARDS 101
11.1.2 INNOVATORS 101
11.1.3 EMERGING 101
11.1.4 DYNAMIC 101
11.2 COMPETITIVE BENCHMARKING 103
11.2.1 PRODUCT PORTFOLIO OF MAJOR PLAYERS IN THE MEDICAL DEVICE REPROCESSING MARKET 103
11.2.2 BUSINESS STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE MEDICAL DEVICE REPROCESSING MARKET 104
11.3 MARKET SHARE ANALYSIS 105
*Top 16 companies analysed for this study are - Stryker Corporation (U.S.), VANGUARD AG (Germany), Johnson & Johnson (U.S.), Medtronic plc (Ireland), Medline ReNewal (U.S.), SteriPro Canada, Inc. (Canada), Pioneer Medical Devices AG (Germany), Vascular Solutions, Inc. (U.S.), HYGIA Health Services, Inc. (U.S.), ReNeMedical, Inc. (U.S.), SureTek Medical (U.S.), Centurion Medical Products Corporation (U.S.), Innovative Health, LLC. (U.S.), NEScientific, Inc. (U.S.), AGITO MEDICAL A/S (Denmark), and Synergy Health plc (U.K.).
?
12 COMPANY PROFILES 106
(Overview, Products and Services, Financials, Strategy & Development)*
12.1 STRYKER CORPORATION 106
12.2 VANGUARD AG 109
12.3 JOHNSON & JOHNSON (J&J) (STERILMED, INC.) 111
12.4 MEDTRONIC PLC 114
12.5 MEDLINE RENEWAL 117
12.6 STERIPRO CANADA INC. 120
12.7 PIONEER MEDICAL DEVICES AG 122
12.8 VASCULAR SOLUTIONS, INC. 124
12.9 HYGIA HEALTH SERVICES, INC. 127
12.10 RENU MEDICAL, INC. 129
12.11 SURETEK MEDICAL 131
12.12 CENTURION MEDICAL PRODUCTS CORPORATION 133
*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.
13 APPENDIX 135
13.1 INSIGHTS OF INDUSTRY EXPERTS 135
13.2 DISCUSSION GUIDE 136
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 139
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 141
13.5 AVAILABLE CUSTOMIZATIONS 143
13.6 RELATED REPORT 144
13.7 AUTHOR DETAILS 145
1 INTRODUCTION 13
1.1 OBJECTIVES OF THE STUDY 13
1.2 MARKET DEFINITION 13
1.3 MARKET SCOPE 14
1.3.1 MARKETS COVERED 14
1.3.2 YEARS CONSIDERED FOR THE STUDY 15
1.4 CURRENCY 15
1.5 LIMITATIONS 15
1.6 STAKEHOLDERS 15
2 RESEARCH METHODOLOGY 16
2.1 RESEARCH APPROACH 16
2.1.1 SECONDARY SOURCES 17
2.1.1.1 Key data from secondary sources 17
2.1.2 PRIMARY SOURCES 18
2.1.2.1 Key data from primary sources 18
2.1.2.2 Key industry insights 19
2.2 MARKET SIZE ESTIMATION 20
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 22
2.4 MARKET SHARE ESTIMATION 23
2.5 ASSUMPTIONS FOR THE STUDY 23
3 EXECUTIVE SUMMARY 24
4 PREMIUM INSIGHTS 28
4.1 GLOBAL MEDICAL DEVICE REPROCESSING MARKET OVERVIEW 28
4.2 GLOBAL MEDICAL DEVICE REPROCESSING MARKET, BY TYPE OF DEVICE,
2017 VS, 2022 29
4.3 MEDICAL DEVICE REPROCESSING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 30
4.4 MEDICAL DEVICE REPROCESSING MARKET: GEOGRAPHIC MIX 31
5 MARKET OVERVIEW 32
5.1 INTRODUCTION 33
5.2 MARKET DYNAMICS 33
5.2.1 DRIVERS 34
5.2.1.1 Low prices of reprocessed medical devices 34
5.2.1.2 Pressure to reduce volume of regulated medical waste 35
?
5.2.2 RESTRAINTS 35
5.2.2.1 Risk of surgical site infections 35
5.2.3 OPPORTUNITIES 36
5.2.3.1 Regulatory changes favoring the adoption of medical device reprocessing 36
5.2.4 KEY CHALLENGES 37
5.2.4.1 Stringent regulations for medical device reprocessing practices 37
6 REGULATORY ANALYSIS 38
6.1 INTRODUCTION 38
6.1.1 NORTH AMERICA 39
6.1.1.1 U.S. 39
6.1.1.2 Canada 40
6.1.2 EUROPE 41
6.1.2.1 Germany 42
6.1.2.2 Rest of Europe 42
6.1.3 ASIA-PACIFIC (APAC) 42
6.1.3.1 Japan 42
6.1.3.2 Australia 42
6.1.3.3 Rest of APAC 42
6.1.4 LATIN AMERICA 43
6.1.5 MIDDLE EAST & AFRICA 43
7 GLOBAL MEDICAL DEVICE REPROCESSING MARKET,
BY PRODUCT & SERVICE 44
7.1 INTRODUCTION 45
7.2 REPROCESSING SUPPORT AND SERVICES 45
7.3 REPROCESSED MEDICAL DEVICES 47
8 GLOBAL MEDICAL DEVICE REPROCESSING MARKET,
BY TYPE OF MEDICAL DEVICE 50
8.1 INTRODUCTION 51
8.2 CATHETERS 52
8.3 LAPAROSCOPY INSTRUMENTS 53
8.4 CABLES, COLUMNS, CURVES, AND CUTTERS 54
8.5 BIOPSY INSTRUMENTS 55
8.6 ENDOSCOPY INSTRUMENTS 56
8.7 OTHER REPROCESSED MEDICAL DEVICES 57
?
9 GLOBAL MEDICAL DEVICE REPROCESSING MARKET, BY APPLICATION 58
9.1 INTRODUCTION 59
9.2 CARDIOLOGY 60
9.3 GASTROENTEROLOGY, UROLOGY, AND GYNECOLOGY 61
9.4 ARTHROSCOPY AND ORTHOPEDIC SURGERY 63
9.5 GENERAL SURGERY AND ANESTHESIA 64
10 GLOBAL MEDICAL DEVICE REPROCESSING MARKET, BY REGION 65
10.1 INTRODUCTION 66
10.2 NORTH AMERICA 68
10.2.1 U.S. 72
10.2.2 CANADA 74
10.3 EUROPE 76
10.3.1 GERMANY 80
10.3.2 U.K. 82
10.3.3 FRANCE 84
10.3.4 REST OF EUROPE 86
10.4 ASIA-PACIFIC 87
10.4.1 AUSTRALIA 90
10.4.2 JAPAN 92
10.5 REST OF THE WORLD (ROW) 94
10.5.1 LATIN AMERICA 96
10.5.2 MIDDLE EAST AND AFRICA 98
11 COMPETITIVE LANDSCAPE 101
11.1 VENDOR DIVE OVERVIEW 101
11.1.1 VANGUARDS 101
11.1.2 INNOVATORS 101
11.1.3 EMERGING 101
11.1.4 DYNAMIC 101
11.2 COMPETITIVE BENCHMARKING 103
11.2.1 PRODUCT PORTFOLIO OF MAJOR PLAYERS IN THE MEDICAL DEVICE REPROCESSING MARKET 103
11.2.2 BUSINESS STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE MEDICAL DEVICE REPROCESSING MARKET 104
11.3 MARKET SHARE ANALYSIS 105
*Top 16 companies analysed for this study are - Stryker Corporation (U.S.), VANGUARD AG (Germany), Johnson & Johnson (U.S.), Medtronic plc (Ireland), Medline ReNewal (U.S.), SteriPro Canada, Inc. (Canada), Pioneer Medical Devices AG (Germany), Vascular Solutions, Inc. (U.S.), HYGIA Health Services, Inc. (U.S.), ReNeMedical, Inc. (U.S.), SureTek Medical (U.S.), Centurion Medical Products Corporation (U.S.), Innovative Health, LLC. (U.S.), NEScientific, Inc. (U.S.), AGITO MEDICAL A/S (Denmark), and Synergy Health plc (U.K.).
?
12 COMPANY PROFILES 106
(Overview, Products and Services, Financials, Strategy & Development)*
12.1 STRYKER CORPORATION 106
12.2 VANGUARD AG 109
12.3 JOHNSON & JOHNSON (J&J) (STERILMED, INC.) 111
12.4 MEDTRONIC PLC 114
12.5 MEDLINE RENEWAL 117
12.6 STERIPRO CANADA INC. 120
12.7 PIONEER MEDICAL DEVICES AG 122
12.8 VASCULAR SOLUTIONS, INC. 124
12.9 HYGIA HEALTH SERVICES, INC. 127
12.10 RENU MEDICAL, INC. 129
12.11 SURETEK MEDICAL 131
12.12 CENTURION MEDICAL PRODUCTS CORPORATION 133
*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.
13 APPENDIX 135
13.1 INSIGHTS OF INDUSTRY EXPERTS 135
13.2 DISCUSSION GUIDE 136
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 139
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 141
13.5 AVAILABLE CUSTOMIZATIONS 143
13.6 RELATED REPORT 144
13.7 AUTHOR DETAILS 145
